Dr. Kalbasi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-723-4000
Education & Training
University of Pennsylvania Health SystemResidency, Radiation Oncology, 2012 - 2016- University of Pennsylvania Health SystemInternship, Internal Medicine, 2011 - 2012
David Geffen School of Medicine at UCLAClass of 2011
Certifications & Licensure
CA State Medical License 2016 - 2026
PA State Medical License 2011 - 2016- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- Inductee Alpha Omega Alpha Honor Medical Society, 2011
Clinical Trials
- Gene Modified Immune Cells (IL13Ralpha2 CAR T Cells) After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors Start of enrollment: 2019 Nov 27
- Nivolumab and BO-112 Before Surgery for the Treatment of Resectable Soft Tissue Sarcoma Start of enrollment: 2020 Oct 29
Publications & Presentations
PubMed
- Gold-siRNA supraclusters enhance the anti-tumor immune response of stereotactic ablative radiotherapy at primary and metastatic tumors.Yuyan Jiang, Hongbin Cao, Huaping Deng, Li Guan, Jimpi Langthasa
Nature Biotechnology. 2024-10-24 - 1 citationsThe landscape of drug sensitivity and resistance in sarcoma.Ahmad Al Shihabi, Peyton J Tebon, Huyen Thi Lam Nguyen, Jomjit Chantharasamee, Sara Sartini
Cell Stem Cell. 2024-10-03 - ASO Visual Abstract: Lifelong Imaging Surveillance is Indicated for Patients with Primary Retroperitoneal Liposarcoma.Mark A Eckardt, Danielle S Graham, Kyle D Klingbeil, Serena Y Lofftus, Tyler R McCaw
Annals of Surgical Oncology. 2023-05-01
Press Mentions
Modified Salmonella Revs Immune Response, Combats Tumors in MiceFebruary 3rd, 2022- AACR Annual Meeting 2021: NextGen Stars Sessions Featured Research from Early-Career InvestigatorsMay 12th, 2021
- The First Spanish Immunotherapy Has Completed the Phase I Trial in Patients with Immunotherapy-Resistant CancerOctober 30th, 2020
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
